99 related articles for article (PubMed ID: 8505009)
1. Decreased levels of amniotic fluid oxytocinase activity in preeclampsia.
Roy AC; Viegas OA; Sen DK; Ratnam SS
Gynecol Obstet Invest; 1993; 35(3):166-8. PubMed ID: 8505009
[TBL] [Abstract][Full Text] [Related]
2. Oxytocinase activity in human amniotic fluid and its relationship to gestational age.
Roy AC; Kottegoda SR; Viegas OA; Ratnam SS
Obstet Gynecol; 1986 Nov; 68(5):614-8. PubMed ID: 3763071
[TBL] [Abstract][Full Text] [Related]
3. Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia.
Papadopoulou E; Sifakis S; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
Growth Horm IGF Res; 2006; 16(5-6):290-6. PubMed ID: 16996762
[TBL] [Abstract][Full Text] [Related]
4. An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.
Park CW; Park JS; Shim SS; Jun JK; Yoon BH; Romero R
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):984-9. PubMed ID: 16157098
[TBL] [Abstract][Full Text] [Related]
5. Oxytocinase-immunohistochemical demonstration in the immature and term human placenta.
Small CW; Watkins WB
Cell Tissue Res; 1975 Oct; 162(4):531-9. PubMed ID: 1102106
[TBL] [Abstract][Full Text] [Related]
6. Activities of some peptidases and glycolytic enzymes in cells of the amniotic fluid. II. Pregnancies complicated by threatening intrauterine fetal asphyxia.
Sward J; Woytoń J; Ilczyszyn J; Dobryszycka W; Narczewska B; Warwas M; Woźniak M
Arch Immunol Ther Exp (Warsz); 1977; 25(3):429-32. PubMed ID: 889430
[TBL] [Abstract][Full Text] [Related]
7. Involvement of fibrinolytic factors in mid trimester amniotic fluid with development of severe early-onset preeclampsia.
Adachi T; Nakabayashi M; Sakura M; Ando K
Semin Thromb Hemost; 1999; 25(5):447-50. PubMed ID: 10625200
[TBL] [Abstract][Full Text] [Related]
8. Change in plasma cystyl aminopeptidase (oxytocinase) between 30-34 weeks' gestation as a predictor of pregnancy-induced hypertension.
Wood PL; Durham BH
Obstet Gynecol; 1988 Dec; 72(6):850-2. PubMed ID: 3186091
[TBL] [Abstract][Full Text] [Related]
9. Proteomic biomarkers in second trimester amniotic fluid that identify women who are destined to develop preeclampsia.
Oh KJ; Park JS; Norwitz ER; Kim SM; Kim BJ; Park CW; Jun JK; Syn HC
Reprod Sci; 2012 Jul; 19(7):694-703. PubMed ID: 22534327
[TBL] [Abstract][Full Text] [Related]
10. Correlation of midtrimester amniotic fluid cytokine concentrations with adverse pregnancy outcome in terms of spontaneous abortion, preterm birth, and preeclampsia.
Bamberg C; Fotopoulou C; Thiem D; Roehr CC; Dudenhausen JW; Kalache KD
J Matern Fetal Neonatal Med; 2012 Jun; 25(6):812-7. PubMed ID: 21726173
[TBL] [Abstract][Full Text] [Related]
11. Mid trimester amniotic fluid soluble receptor tunica interna endothelial cell kinase-2 levels and risk for preeclampsia.
Stipoljev F; Vujisić S; Ježek D; Vičić A; Radmanić L; Papić N; Židovec Lepej S
Pregnancy Hypertens; 2022 Mar; 27():69-73. PubMed ID: 34968946
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandins, not cyclic GMP, inhibit oxytocinase isoenzymes from human amniotic fluid in vitro.
Roy AC; Yeang M; Tan SM; Kottegoda SR; Ratnam SS
Prostaglandins; 1985 Aug; 30(2):255-61. PubMed ID: 2996058
[TBL] [Abstract][Full Text] [Related]
13. Effects of placental proteases on maternal and fetal blood pressure in normal pregnancy and preeclampsia.
Mizutani S; Tomoda Y
Am J Hypertens; 1996 Jun; 9(6):591-7. PubMed ID: 8783784
[TBL] [Abstract][Full Text] [Related]
14. Complement Split Products in Amniotic Fluid in Pregnancies Subsequently Developing Early-Onset Preeclampsia.
Banadakoppa M; Vidaeff AC; Yallampalli U; Ramin SM; Belfort MA; Yallampalli C
Dis Markers; 2015; 2015():263109. PubMed ID: 26556948
[TBL] [Abstract][Full Text] [Related]
15. Elevated fetal fibronectin in midtrimester amniotic fluid is involved with the onset of preeclampsia.
Sakura M; Nakabayashi M; Takeda Y; Sato K
J Obstet Gynaecol Res; 1998 Feb; 24(1):73-6. PubMed ID: 9564109
[TBL] [Abstract][Full Text] [Related]
16. beta-Glucuronidase activity in amniotic fluid.
Kamarýt J; Matýsek P
J Clin Chem Clin Biochem; 1980 Oct; 18(10):611-4. PubMed ID: 7441170
[TBL] [Abstract][Full Text] [Related]
17. [Oxytocinase: levels in normal and pathological pregnancies].
Lambercy JM
J Gynecol Obstet Biol Reprod (Paris); 1979 Jun; 8(4):323-8. PubMed ID: 544681
[TBL] [Abstract][Full Text] [Related]
18. Alteration of circulating Placental Leucine Aminopeptidase (P-LAP) activity in preeclampsia.
Landau R; Laverrière A; Bischof P; Irion O; Morales M; Cohen M
Neuro Endocrinol Lett; 2010; 31(1):63-6. PubMed ID: 20150869
[TBL] [Abstract][Full Text] [Related]
19. Serum cystyl aminopeptidase activity in the 36th week of pregnancy.
Durham BH; Rewell RE
J Clin Pathol; 1979 Apr; 32(4):318-20. PubMed ID: 447865
[TBL] [Abstract][Full Text] [Related]
20. Identification of vasopressor constituents of amniotic fluid in pregnancy toxaemia.
Dhall K; Kumar M; Dhall GI; Jain P; Singh KT; Chakravorti RN
Ric Clin Lab; 1979; 9(1):25-33. PubMed ID: 493811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
